Shortcuts 2018 2017 2016 2014 2013

2018

  • University of Minnesota
    Investigational Therapy Exploring Treatment of Heart Failure Seeks to Stimulate Body’s Natural Healing Response Read More

  • Saint Joseph Mercy
    St. Joseph Mercy Ann Arbor to perform clinical trial using stem cells to treat congestive heart failure Read More

  • BioWorld Med Tech
    Biocardia wins IDE for cell therapy as treatment for angina Read More

2017

  • BioWorld Med Tech
    Biocardia presses on with Cardiamp pivotal trial to treat patients with heart failure Read More

  • Med Latest
    BioCardia® Helix Results in Higher Stem Cell Retention in Myocardium Read More

  • Fox 47
    UW Health trial involves injecting stem cells into patients with heart failure Read More

  • Medical press
    First participant treated in trial of stem-cell therapy for heart failure Read More

  • Cardiology today
    First patient treated in trial of novel cell therapy Read More

  • News Center Watch
    Johns Hopkins, MSCRF, BioCardia treat first patient with CardiAMP in ischemic heart failure trial Read More

  • Drug Delivery
    BioCardia, Johns Hopkins treats first patient with CardiAmp cell therapy in Phase III trial Read More

  • The Baltimore Sun
    Patient's own bone marrow used to treat heart failure Read More

2016

  • Drug Delivery
    BioCardia launches pivotal trial for CardiAmp heart failure treatment Read More

  • Cardiac Interventions
    Studies Presented for BioCardia’s CardiAMP Cell Therapy Read More

2014

  • Cardiology today
    Clinical trial will explore bone marrow-derived cell therapy for HF Read More

  • FDA NEWS
    FDA OKs Phase III Trial of Cell-Based Heart Failure Therapy and Diagnostic Read More

2013

  • DAIC
    Phase II TAC-HFT Trial Suggests Efficacy for Transendocardial Delivery of Autologous Cells for Ischemic Heart Failure Read More

News


Have questions?
CALL US NOW
: (800) 624-1179
Have questions?
EMAIL US NOW
: info@biocardia.com

biocardia takes a new and comprehensive
approach to heart failure

By introducing patient screening and highly-efficient delivery to stem cell therapy, the company seeks to increase the likelihood of treatment success, enabling more patients to return to the things they love.